SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-083200
Filing Date
2024-07-12
Accepted
2024-07-12 16:13:01
Documents
2
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3869
2 EX-24 antx-ex24.htm EX-24 12399
  Complete submission text file 0000950170-24-083200.txt   17663
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3023 MONTBRETIA WAY SAN RAMON CA 94582
Business Address
Eizen Joshua M (Reporting) CIK: 0001949621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 241114605